UBS analyst AJ Rice downgraded Enhabit Home Health & Hospice (NYSE: EHAB) from Buy to Neutral with a price target ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE